These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1809 related articles for article (PubMed ID: 30085333)
1. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review). Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333 [TBL] [Abstract][Full Text] [Related]
2. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA. Junqueira-Neto S; Batista IA; Costa JL; Melo SA Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027 [TBL] [Abstract][Full Text] [Related]
3. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141 [TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes. Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474 [TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer. Levy B; Hu ZI; Cordova KN; Close S; Lee K; Becker D Oncologist; 2016 Sep; 21(9):1121-30. PubMed ID: 27388233 [TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy and its role in an advanced clinical trial for lung cancer. Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770 [TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy: current technology and clinical applications. Nikanjam M; Kato S; Kurzrock R J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in circulating nucleic acids in oncology. Otandault A; Anker P; Al Amir Dache Z; Guillaumon V; Meddeb R; Pastor B; Pisareva E; Sanchez C; Tanos R; Tousch G; Schwarzenbach H; Thierry AR Ann Oncol; 2019 Mar; 30(3):374-384. PubMed ID: 30753271 [TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy: A new avenue in pathology. Ghosh RK; Pandey T; Dey P Cytopathology; 2019 Mar; 30(2):138-143. PubMed ID: 30485558 [TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618 [TBL] [Abstract][Full Text] [Related]
11. Liquid Biopsy: Current Status and Future Perspectives. Mader S; Pantel K Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023 [TBL] [Abstract][Full Text] [Related]
12. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications. Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637 [TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same? Kahlert C Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377 [TBL] [Abstract][Full Text] [Related]
14. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology. Ray SK; Mukherjee S Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128 [TBL] [Abstract][Full Text] [Related]
15. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy. Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516 [TBL] [Abstract][Full Text] [Related]
16. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application. Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662 [TBL] [Abstract][Full Text] [Related]
17. Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes? Zhang W; Xia W; Lv Z; Ni C; Xin Y; Yang L Cell Physiol Biochem; 2017; 41(2):755-768. PubMed ID: 28214887 [TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy in breast cancer: A comprehensive review. Alimirzaie S; Bagherzadeh M; Akbari MR Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931 [TBL] [Abstract][Full Text] [Related]
20. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology. Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]